These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Intraportal islet allografts: the use of a stimulation index to represent functional results. Scharp DW; Lacy PE; Weide LG; Marchetti P; McCullough CS; Flavin K; Santiago JV Transplant Proc; 1991 Feb; 23(1 Pt 1):796-8. PubMed ID: 1990694 [No Abstract] [Full Text] [Related]
36. Induction of allogeneic islet tolerance in a large-animal model. Horton PJ; Hawthorne WJ; Walters SN; Patel AT; O'Connell PJ; Chapman JR; Allen RD Cell Transplant; 2000; 9(6):877-87. PubMed ID: 11202573 [TBL] [Abstract][Full Text] [Related]
37. Human islet retransplantation in a patient with type I diabetes. Triponez F; Oberholzer J; Toso C; Majno P; Martin PY; Morel P Transpl Int; 2002 Apr; 15(4):200-2. PubMed ID: 11976743 [No Abstract] [Full Text] [Related]
38. Oral tolerance and allografts: can multiple oral administrations of low doses of highly purified islets induce peripheral tolerance in pancreatic islet allografts? Senesi B; Curiale V; Lione L; Puddu A; Pedemonte A; Pastorino A; Viviani GL Transplant Proc; 1998 Mar; 30(2):545-9. PubMed ID: 9532171 [No Abstract] [Full Text] [Related]
39. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260 [TBL] [Abstract][Full Text] [Related]